Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
7.38
-0.05 (-0.67%)
Apr 25, 2025, 11:26 AM EDT - Market open
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $786.93 million as of April 25, 2025. Its market cap has decreased by -65.70% in one year.
Market Cap
786.93M
Enterprise Value
445.42M
1-Year Change
-65.70%
Ranking
Category
Stock Price
$7.38
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $786.93M, an increase of 725.74%. That is a compound annual growth rate of 23.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 792.30M | -30.85% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.33B |
| UnitedHealth Group | 387.93B |
| Johnson & Johnson | 372.37B |
| AbbVie | 319.99B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.32B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |